Stocks and Investing Stocks and Investing
Wed, August 23, 2023

Justin Kim Reiterated (APLS) at Buy on, Aug 23rd, 2023


Published on 2024-10-28 06:04:25 - WOPRAI, Justin Kim
  Print publication without navigation


Justin Kim of Oppenheimer, Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Buy on, Aug 23rd, 2023.

Justin has made no other calls on APLS in the last 4 months.



There are 8 other peers that have a rating on APLS. Out of the 8 peers that are also analyzing APLS, 4 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $60 on, Thursday, August 3rd, 2023
  • Brian Cheng of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $40 on, Tuesday, August 1st, 2023
  • Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $53 on, Thursday, July 20th, 2023
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $81 on, Friday, May 5th, 2023


These are the ratings of the 4 analyists that currently disagree with Justin


  • Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $89 on, Tuesday, August 1st, 2023
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $60 on, Monday, July 31st, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $80 on, Friday, July 21st, 2023

Contributing Sources